1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Biofrontera Bioscience GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis BF-200 ALA 1%, BF-200 ALA 3%, BF-200 ALA 10% - Actinic Keratosis | Phase 2 | Completed | Biofrontera Bioscience GmbH | 105 | 2006-10-01 | 2016-07-19 |